British Columbia Cancer Agency
British Columbia Cancer Agency
Explore linked clinical trials.58 results · Page 1 of 3
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CfDNA in Hereditary And High-risk Malignancies 2 | Adnexal Diseases, Colorectal Neoplasms, Hereditary Nonpolyposis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA repair disease, Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Li-Fraumeni syndrome, Neoplasms by Site, Nutritional and Metabolic Diseases, Skin and Connective Tissue Diseases, Urogenital Diseases, Urogenital Neoplasms, breast disorder, breast neoplasm, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gastric neoplasm, gonadal disorder, hereditary breast ovarian cancer syndrome, hereditary disease, hereditary neoplastic syndrome, intestinal disorder, malignant endocrine neoplasm, metabolic disease, neoplasm, ovarian cancer, ovarian disorder, skin disorder, stomach disorder | Recruiting | Not stated | 2026-10-08 | NCT06726642 | |
| A Comparison of [68Ga]DOTATATE and [18F]AmBF3TATE for the Staging and Assessment of Neuroendocrine Malignancies | Carcinoma, Medullary, Neoplasms by Histologic Type, Neoplasms, Ductal, Lobular, and Medullary, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, adenocarcinoma, carcinoma, epithelial neoplasm, medullary thyroid gland carcinoma, neoplasm, neuroendocrine carcinoma, neuroendocrine neoplasm, paraganglioma, pheochromocytoma, pheochromocytoma-paraganglioma, primitive neuroectodermal tumor | Not yet recruiting | Not stated | 2026-10-06 | NCT07621146 | |
| First-Line Sacituzumab Govitecan in Advanced Untreated Triple-Negative Breast Cancer Patients. | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Recruiting | Phase 2 | 2026-10-06 | NCT07299409 | |
| The Impact of Time-of-day Administration of EV/P on Objective Response Rate in Adults With Advanced Bladder Cancer | Advanced Bladder Cancer | Not yet recruiting | Phase 3 | 2026-10-01 | NCT07346053 | |
| The Impact of Time-of-day-Dependent Administration of Nivolumab-Ipilimumab (ICI/ICI) Combination on Overall Survival in Adults With Advanced Kidney Cancer: A Pragmatic Multicenter, Randomized Controlled Trial. | Advanced Kidney Cancer | Not yet recruiting | Phase 3 | 2026-10-01 | NCT07338981 | |
| Preliminary Assessment of [18F]BL40 in PET/CT Scans | B-cell chronic lymphocytic leukemia, B-cell neoplasm, Blood Protein Disorders, Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, B-Cell, Lymphoma, B-Cell, Marginal Zone, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Waldenstrom macroglobulinemia, cardiovascular disorder, diffuse large B-cell lymphoma, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, mantle cell lymphoma, marginal zone lymphoma, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Not stated | 2026-10-01 | NCT06224309 | |
| Stereotactic Ablative Body Radiotherapy (SABR) for Oligometastases | Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasm | Active, not recruiting | Not applicable | 2026-10-01 | NCT02933242 | |
| HELP Study - Towards High Throughput and Efficient Long-axial PET With Oral [18F]FDG | Feasibility Studies; Multiple Cancers; Multiple Indications Cancer | Active, not recruiting | Not applicable | 2026-09-29 | NCT07295171 | |
| Comprehensive Genomic Profiling of Colorectal Cancer Patients With Isolated Liver Metastases to Understand Response & Resistance to Cancer Therapy | Digestive System Diseases, Digestive System Neoplasms, Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Active, not recruiting | Not stated | 2026-09-28 | NCT03364621 | |
| RAPid SimPLE Targeted Radiation Treatment for Brain Metastases | Neoplasms by Site, brain disorder, central nervous system cancer, central nervous system disorder, neoplasm, nervous system disorder | Active, not recruiting | Phase 2 | 2026-09-21 | NCT05050929 | |
| Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment | pancreatic ductal adenocarcinoma | Recruiting | Not applicable | 2026-09-16 | NCT06574620 | |
| Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity | Cancer of Gastrointestinal Tract, Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genitourinary Cancer, Head and Neck Neoplasms, Male Urogenital Diseases, Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, Neoplasms, Unknown Primary, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, Thoracic Neoplasms, Unknown Primary Tumors, Urogenital Diseases, Urogenital Neoplasms, breast cancer, breast disorder, breast neoplasm, digestive system disorder, digestive system neoplasm, female reproductive organ cancer, head and neck cancer, lung cancer, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, sarcoma, skin disorder, skin neoplasm | Recruiting | Phase 2 | 2026-09-16 | NCT04273061 | |
| Using Strength Tests to Better Understand How Pancreatic Cancer Affects Muscle Mass and Quality of Life | Atrophy, Body Weight, Body Weight Changes, Cachexia, Neurologic Manifestations, Neuromuscular Manifestations, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Sarcopenia, Signs and Symptoms, Thinness, Weight Loss, muscular atrophy, nervous system disorder | Recruiting | Not applicable | 2026-09-15 | NCT07255001 | |
| Monitoring and Managing Glucose Levels in People With Pancreatic Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Nutritional and Metabolic Diseases, endocrine system disorder, glucose metabolism disease, hyperglycemia, malignant endocrine neoplasm, malignant pancreatic neoplasm, metabolic disease, neoplasm, pancreas disorder, pancreatic neoplasm | Recruiting | Not applicable | 2026-09-14 | NCT05132244 | |
| Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, cancer, endocrine system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Recruiting | Not stated | 2026-09-14 | NCT02869802 | |
| Single vs Hypofractionated Irradiation For Timely Access to Partial Breast Radiotherapy | Breast Cancer Early Stage Breast Cancer (Stage 1-3) | Recruiting | Not applicable | 2026-08-26 | NCT06885671 | |
| High Dose Radiotherapy for Palliation (Hi-D) | Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasm | Not yet recruiting | Not applicable | 2026-08-12 | NCT07291895 | |
| A Model for Genetic Susceptibility: Melanoma | Disease Attributes, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, disease susceptibility, inherited disease susceptibility, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm | Active, not recruiting | Not stated | 2026-08-05 | NCT00591500 | |
| Partial Prostate Salvage High Dose Rate Brachytherapy | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Not applicable | 2026-06-29 | NCT03246802 | |
| Comparison of HDR vs. LDR Brachytherapy as Monotherapy for Intermediate Risk Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Active, not recruiting | Phase 3 | 2026-06-29 | NCT02692105 | |
| Phase II Randomized Trial of 2 Versus 5 Fraction Prostate Stereotactic Ablative Radiotherapy for Intermediate Risk Prostate Cancer | Prostate CA | Recruiting | Phase 2 | 2026-06-24 | NCT06835725 | |
| A Prospective Cohort Study Evaluating Risk of Local Recurrence Following Breast Conserving Surgery and Endocrine Therapy in Low Risk Luminal A Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Not stated | 2026-06-17 | NCT01791829 | |
| DOTATOC PET/CT for Imaging NET Patients | Adenoma, Islet Cell, Carcinoma, Medullary, DNA Virus Infections, Digestive System Diseases, Digestive System Neoplasms, Infections, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Ductal, Lobular, and Medullary, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, Pituitary Neoplasms, Thoracic Neoplasms, Tumor Virus Infections, VIPoma, adenocarcinoma, adenoma, brain disorder, bronchial neoplasm, bronchogenic carcinoma, carcinoid tumor, carcinoma, central nervous system cancer, central nervous system disorder, cutaneous neuroendocrine carcinoma, endocrine system disorder, epithelial neoplasm, glioma, glucagonoma, hypothalamic disorder, hypothalamic neoplasm, lung disorder, lung neoplasm, malignant endocrine neoplasm, medulloblastoma, meningioma, neoplasm, nervous system disorder, neuroblastoma, neuroendocrine carcinoma, neuroendocrine neoplasm, neuroepithelial neoplasm, pancreas disorder, pancreatic endocrine carcinoma, pancreatic insulinoma, pancreatic neoplasm, paraganglioma, pheochromocytoma, pituitary gland adenoma, pituitary gland disorder, polyomavirus infectious disease, primitive neuroectodermal tumor, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma, supratentorial cancer, tumor of meninges, vascular cancer, viral infectious disease | Active, not recruiting | Not stated | 2026-05-12 | NCT03583528 | |
| 5500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT) | Oligometastatic Prostate Cancer | Recruiting | Not applicable | 2026-05-06 | NCT04610372 | |
| Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic (1-3 Metastases) Cancer | Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasm | Active, not recruiting | Not applicable | 2026-04-29 | NCT03862911 |